Applied Clinical Trials-01-01-2005

Pharmaceutical companies need to integrate pediatric assessments into the standard drug development process and build up pediatric competence.

Weyers, Wolfgang (New York: Ardor Schribendi, Ltd., 2003) 755 pages.

Orphan drug development may take a back seat to profit and loss concerns.

Inadequate pre-approval testing and information disclosure may slow new drug development and change regulations.

The data obtained by The Bellagio Child Survival Study Group has made the identification of priority research subjects more precise and relevant to developing countries.

The Pediatric Rule made everyone begin to assess, think, and plan for pediatric needs.

The traditional, "ideal" consent situation favors the immediate decision maker.

Think of Teranode's modeling software program as the world's most sophisticated blackboard